A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
1d
AZoLifeSciences on MSNPanK4 Protein Could Be Key to Better Control of Blood Sugar and MetabolismPhysical activity is not only important for fitness, but also for health. This is confirmed by a new study conducted under ...
Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
The Fast Track designation is supported by data from a phase 2 trial that evaluated eRapa in 30 adult patients with FAP.
15d
News Medical on MSNA new therapeutic target for a lethal form of heart failure: ALPK2Heart failure with preserved ejection function is a lethal form of heart failure, with few effective treatments. A team from Nagoya University Graduate School of Medicine have identified an enzyme, ...
The company granted stock options to purchase an aggregate of 208,350 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 272,850 shares of Nurix common ...
3d
News Medical on MSNAdrenomedullin hormone as key driver of insulin resistance in obesity-linked type 2 diabetesResearchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.
Mitogen-Activated Protein Kinase (MAPK) signaling pathways play a crucial role in various cellular processes, including growth, differentiation, and response to stress. These pathways are ...
The table below is a review of notable updates that occurred in January 2025 for investigational products in development.
Researchers discovered that ALPK2, a heart-specific enzyme, may protect against HFpEF by activating TPM1 in heart muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results